Introducing BluNiche’s Innovative Pharmaceutical Product Recall Insurance

BluNiche, a London-based product recall specialist Managing General Agent (MGA), has announced the launch of its new Pharmaceutical Recall Insurance product. This initiative marks a significant expansion of its portfolio, aimed at providing dedicated coverage specifically for the pharmaceutical sector.

The newly introduced offering delivers comprehensive recall protection tailored for a variety of stakeholders within the pharmaceutical industry. This includes pharmaceutical companies, contract manufacturers, contract packers, distributors, and Active Pharmaceutical Ingredient (API) manufacturers operating on a global scale.

BluNiche possesses the specialized capabilities necessary to understand the unique risks faced by its clients. The company is committed to tailoring solutions that provide robust balance sheet protection in the event of a recall. The insurer has emphasized its focus on collaborating with brand-name drug manufacturers, generic drug producers, and biologic drug companies.

“At BluNiche, we only underwrite product recall insurance,” stated Neil Evans, the founder of BluNiche. “Our senior underwriter, Alex King, has leveraged his extensive experience in underwriting pharmaceutical risks over many years to shape this coverage around the specific challenges faced by pharmaceutical businesses. I’m extremely thankful to Alex and proud to work alongside such a strong team with deep technical expertise.”

Alex King added, “The pharmaceutical industry, where most recall issues tend to be batch or run specific—such as mislabeling, micro-contamination, or packaging defects—has very specific recall needs. We’re delighted to now provide this critical support to the industry.”

BluNiche’s pharmaceutical recall policies are backed by “A+” S&P-rated Lloyd’s security. The coverage includes recall costs, loss of profits, and crisis consultancy services, offering invaluable balance sheet protection in the event of a recall.

These new Pharmaceutical Recall Insurance policies are now available through broker partners, making it easier for clients to access this essential coverage.

Founded in 2022 by product recall veteran Neil Evans, BluNiche specializes in providing product recall insurance for clients seeking balance sheet protection and crisis management. In addition to pharmaceutical manufacturers, BluNiche also offers product recall protection for food and beverage manufacturers, restaurants, packaging companies, retailers, finished goods manufacturers, and auto component manufacturers.

Source: BluNiche

Topics
New Markets

BluNiche, a London-based product recall specialist Managing General Agent (MGA), has announced the launch of its new Pharmaceutical Recall Insurance product. This initiative marks a significant expansion of its portfolio, aimed at providing dedicated coverage specifically for the pharmaceutical sector.

The newly introduced offering delivers comprehensive recall protection tailored for a variety of stakeholders within the pharmaceutical industry. This includes pharmaceutical companies, contract manufacturers, contract packers, distributors, and Active Pharmaceutical Ingredient (API) manufacturers operating on a global scale.

BluNiche possesses the specialized capabilities necessary to understand the unique risks faced by its clients. The company is committed to tailoring solutions that provide robust balance sheet protection in the event of a recall. The insurer has emphasized its focus on collaborating with brand-name drug manufacturers, generic drug producers, and biologic drug companies.

“At BluNiche, we only underwrite product recall insurance,” stated Neil Evans, the founder of BluNiche. “Our senior underwriter, Alex King, has leveraged his extensive experience in underwriting pharmaceutical risks over many years to shape this coverage around the specific challenges faced by pharmaceutical businesses. I’m extremely thankful to Alex and proud to work alongside such a strong team with deep technical expertise.”

Alex King added, “The pharmaceutical industry, where most recall issues tend to be batch or run specific—such as mislabeling, micro-contamination, or packaging defects—has very specific recall needs. We’re delighted to now provide this critical support to the industry.”

BluNiche’s pharmaceutical recall policies are backed by “A+” S&P-rated Lloyd’s security. The coverage includes recall costs, loss of profits, and crisis consultancy services, offering invaluable balance sheet protection in the event of a recall.

These new Pharmaceutical Recall Insurance policies are now available through broker partners, making it easier for clients to access this essential coverage.

Founded in 2022 by product recall veteran Neil Evans, BluNiche specializes in providing product recall insurance for clients seeking balance sheet protection and crisis management. In addition to pharmaceutical manufacturers, BluNiche also offers product recall protection for food and beverage manufacturers, restaurants, packaging companies, retailers, finished goods manufacturers, and auto component manufacturers.

Source: BluNiche

Topics
New Markets